Systm Wealth Solutions LLC Takeda Pharmaceutical CO LTD Transaction History

Systm Wealth Solutions LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$12.6 - $13.67 $35,267 - $38,262	-2,799 Reduced 37.43%	4,679 $60.5 Million
Q1 2024 Apr 26, 2024	SELL	$13.89 - $15.04 $42,892 - $46,443	-3,088 Reduced 29.23%	7,478 $104 Million
Q4 2023 Feb 14, 2024	SELL	$13.36 - $15.43 $10,006 - $11,557	-749 Reduced 6.62%	10,566 $151 Million
Q3 2023 Nov 14, 2023	SELL	$15.03 - $16.32 $2,014 - $2,186	-134 Reduced 1.17%	11,315 $175 Million
Q2 2023 Aug 14, 2023	BUY	$15.57 - $17.11 $7,816 - $8,589	502 Added 4.59%	11,449 $180 Million
Q1 2023 May 12, 2023	SELL	$15.28 - $16.48 $20,964 - $22,610	-1,372 Reduced 11.14%	10,947 $180 Million
Q4 2022 Feb 10, 2023	BUY	$12.42 - $15.62 $153,001 - $192,422	12,319 New	12,319 $192 Million

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Systm Wealth Solutions LLC, based on Form 13F filings with the SEC.

Stay updated on Systm Wealth Solutions LLC with notifications on news.